Purpose: Artificial corneas or keratoprostheses such as the Boston keratoprosthesis (KPro) are being used more frequently to provide a clear corneal window in patients with severe corneal disease. A significant percentage of patients who undergo Boston KPro implantation require subsequent eyelid surgery. However, few articles in peer-reviewed literature evaluate the indication and outcome of eyelid procedures after Boston KPro implantation. This study examines the frequency, nature, and outcomes of oculoplastic procedures in patients with Boston KPro implantation.
Methods: A retrospective chart review was conducted of all KPro-1 procedures performed at the University of Illinois at Chicago between December 2006 and September 2010 and all KPro-1 and KPro-2 procedures performed at the University of Iowa between December 2008 and October 2010.
Results: One hundred and twenty eyes underwent Boston KPro-1 procedures, and 2 eyes underwent Boston KPro-2 procedures. Twenty-one (17.2%) of the 122 eyes required subsequent eyelid alterations. Chemical burn was the most common preoperative corneal diagnosis (8 of 21; 38.1%). A variety of oculoplastic procedures were performed; the most common procedure was a permanent lateral tarsorrhaphy. Seventeen (81.0%) of 21 KPro eyes that underwent oculoplastic procedures maintained the KPro at an average of 12.4 months of follow up.
Conclusions: A significant number of patients with Boston KPros require subsequent eyelid surgery. With limited existing literature and increasing popularity for using Boston KPros to treat severe corneal disease, it is essential for oculoplastic and corneal surgeons to understand the need for eyelid alterations in these patients and the surgical intricacies surrounding these cases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/IOP.0b013e31825b648e | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
TNF-α Suppression Attenuates Limbal Stem Cell Damage in Ocular Injury.
Cornea
December 2024
Department of Ophthalmology, Massachusetts Eye and Ear and Schepens Eye Research Institute, Harvard Medical School, Boston, MA.
Purpose: Ocular chemical injuries often cause uveal inflammation, upregulation of TNF-α at the limbus, and subsequent limbal stem cell (LSC) damage. In this study, we investigate the protective role of TNF-α suppression in LSC survival.
Methods: Corneal alkali injuries were performed using NaOH as previously described by our group.
[Retroprosthetic membrane formation in Boston keratoprosthesis type 1: Incidence, predisposing factors, complications, and treatment].
J Fr Ophtalmol
October 2023
Département d'ophtalmologie, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montréal, Canada.
Objective: Evaluate the incidence and risk factors for retroprosthetic membrane (RPM) formation after Boston keratoprosthesis type 1 (BKpro), identify the associated complications and describe the treatments offered.
Methods: Retrospective cohort study. In total, 133 eyes of 115 patients who underwent BKpro at Centre Hospitalier de l'Université de Montréal (CHUM) from 2008 to 2017, with a minimum follow-up of 1 year, were included in the study.
Clinical Outcomes of Stage 2 (Pivotal) Use of a Modified Keratoprosthesis Device (ORC-KPro) in Patients with End-stage Corneal Blindness.
J Ophthalmic Vis Res
September 2024
Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Article Synopsis
- The study aimed to evaluate the short-term outcomes of a modified Boston keratoprosthesis device (ORC-KPro) in patients suffering from end-stage corneal blindness.
- It included 12 patients (mostly middle-aged and male) where corneal blindness was primarily due to chemical burns or previous graft failures, achieving anatomical success for all cases.
- While most patients experienced improved vision post-surgery, functional success was restricted because of underlying severe eye conditions, impacting overall visual potential.
Visual restoration with KPro after face allotransplantation with a grade III phthisical eye.
Digit J Ophthalmol
July 2024
Retina Service and Cornea Service, Department of Ophthalmology, Mass Eye and Ear, Mass General Brigham Harvard Medical School, Boston, Massachusetts.
The Boston Keratoprosthesis type I (KPro-I) has been shown to be successful in restoring vision after severe ocular burns; however, its long-term outcomes in phthisical eyes have rarely been reported. A monocular woman with a history of severe alkali chemical injury necessitating facial transplantation presented with a light perception left eye after a complicated course, including failed KPro-I, therapeutic penetrating keratoplasty, endophthalmitis, hypotony, total retinal detachment, and structural changes, including a shrunken 18 mm axial length and eye wall thickening. The patient underwent a combined vitrectomy with silicone oil and KPro-I implantation, resulting in her regaining ambulatory visual acuity (20/250) at 3 years' follow-up
View Article and Find Full Text PDF[ARTIFICIAL CORNEA: FROM THE BEGINNING TO THE FUTURE].
Harefuah
May 2024
Department of Ophthalmology, Rabin Medical Center, Petach Tikva, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Corneal disease is among the leading reversible causes of blindness worldwide. Corneal transplantation is a successful and curative treatment for most of these cases. However, in certain indications it is not amendable for standard corneal transplantation, the only available option to restore functional vision is keratoprosthesis (KPro) implantation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!